Insights On Upstream Manufacturing
-
A Simple, Scalable, And Reproducible Hydration Process For Biologics Production
11/17/2026
A concentrated CHO feed can deliver strong fed-batch performance, yet its liquid form was once too unstable to sell, leaving users to hydrate powder and manage mixing time on their own.
-
Set Your Own Intensity: When Economics Drives The Decision
11/13/2026
Process intensification has no universal lowest-cost architecture. The right economic choice follows the manufacturing constraint, and it can shift as demand, scale, and productivity limits change.
-
Set Your Own Intensity: When Flexibility Matters Most
11/13/2026
Intensifying one operation often shifts the constraint to another. Real flexibility depends on designing cadence, capacity, connections, and control, and on choosing how connected a workflow should be.
-
Set Your Own Intensity: When You Need More Speed
11/13/2026
Going faster is not the same as making a process faster. Cutting time built into manufacturing means removing seed stages, holds, and recirculation, while confirming downstream steps can absorb the gain.
-
Set Your Own Intensity: When You Need More Output
11/13/2026
Raising bioreactor output without adding vessel size means choosing between strategies, then confirming that harvest, capture, and purification can absorb the additional product.
-
Set Your Own Intensity: Rethink What Is Possible
11/13/2026
Process intensification is a menu of strategies, not a single route. Starting from the constraint holding a process back, rather than from added capacity, shapes which level of change fits.
-
Rethinking Fixed Processes In Cell Therapy Development
11/11/2026
In cell therapy development, the process often bends to fit the equipment, and a workaround that felt manageable at the lab bench can become a quality deviation risk once manufacturing begins.
-
Upstream Process Intensification With Dynamic Perfusion
11/9/2026
A fixed-feed approach to perfusion offers a simpler route to intensification, matching steady-state productivity at 50 L scale while consuming less media and requiring fewer operator interactions.
-
Designing ADC Manufacturing For Operator And Patient Safety
11/6/2026
ADC manufacturing succeeds when manufacturability is treated as an early design input. Cell line choices, toxic payload handling, and single-use extractables each shape operator exposure and risk.
-
Simplifying Custom Media From Development To GMP With An End-To-End Approach
11/6/2026
Custom media manufacturing across US and European sites, paired with rapid prototyping of proprietary formulations as a scale-down model, shapes how teams move cell culture processes toward GMP production.